deltatrials
Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06704009

NT-101 Topical Ophthalmic Solution in Patients With Wet AMD

A Randomized, Open-Label, Parallel-group, Multicenter Phase 1/2 Study to Evaluate the Safety and Exploratory Efficacy of NT-101 Topical Ophthalmic Solution in Patients With Wet Age-Related Macular Degeneration (AMD)

Sponsor: KCRN Research, LLC

Conditions Wet AMD Wet Age Related Macular Degeneration
Interventions NT-101 High Dose NT-101 Low Dose
Updated 6 times since 2024 Last updated: Oct 28, 2025 Started: Mar 11, 2025 Primary completion: Dec 30, 2025 Completion: Mar 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06704009, this PHASE1/PHASE2 trial focuses on Wet AMD and Wet Age Related Macular Degeneration and remains ongoing. Sponsored by KCRN Research, LLC, it has been updated 6 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2024 – ~Apr 2025 · 4 months · monthly snapshotNot Yet Recruiting~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Nov 2025 · 4 months · monthly snapshotRecruiting~Nov 2025 – present · 8 months · monthly snapshotActive Not Recruiting

Change History

6 versions recorded

  1. Nov 2025 — Present [monthly]

    Active Not Recruiting PHASE1/PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Jul 2025 — Nov 2025 [monthly]

    Recruiting PHASE1/PHASE2

  3. Jun 2025 — Jul 2025 [monthly]

    Recruiting PHASE1/PHASE2

  4. May 2025 — Jun 2025 [monthly]

    Recruiting PHASE1/PHASE2

  5. Apr 2025 — May 2025 [monthly]

    Recruiting PHASE1/PHASE2

    Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

  1. Dec 2024 — Apr 2025 [monthly]

    Not Yet Recruiting PHASE1/PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • KCRN Research, LLC
  • NexThera Co., Ltd.
Data source: NexThera Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations